149 related articles for article (PubMed ID: 23584015)
1. Gold amides as anticancer drugs: synthesis and activity studies.
Newcombe S; Bobin M; Shrikhande A; Gallop C; Pace Y; Yong H; Gates R; Chaudhuri S; Roe M; Hoffmann E; Viseux EM
Org Biomol Chem; 2013 May; 11(19):3255-60. PubMed ID: 23584015
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, cytotoxicity and anti-cancer activity of new alkynyl-gold(I) complexes.
De Nisi A; Bergamini C; Leonzio M; Sartor G; Fato R; Naldi M; Monari M; Calonghi N; Bandini M
Dalton Trans; 2016 Jan; 45(4):1546-53. PubMed ID: 26687209
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterization and cytotoxicity of the gold(III) complexes of 4,5-dihydropyrazole-1-carbothioamide derivatives.
Wang S; Shao W; Li H; Liu C; Wang K; Zhang J
Eur J Med Chem; 2011 May; 46(5):1914-8. PubMed ID: 21392862
[TBL] [Abstract][Full Text] [Related]
4. Exploring the C^N^C theme: Synthesis and biological properties of tridentate cyclometalated gold(III) complexes.
Jürgens S; Scalcon V; Estrada-Ortiz N; Folda A; Tonolo F; Jandl C; Browne DL; Rigobello MP; Kühn FE; Casini A
Bioorg Med Chem; 2017 Oct; 25(20):5452-5460. PubMed ID: 28823538
[TBL] [Abstract][Full Text] [Related]
5. Gold(I) complexes with alkylated PTA (1,3,5-triaza-7-phosphaadamantane) phosphanes as anticancer metallodrugs.
García-Moreno E; Gascón S; Atrián-Blasco E; Rodriguez-Yoldi MJ; Cerrada E; Laguna M
Eur J Med Chem; 2014 May; 79():164-72. PubMed ID: 24732792
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo studies of gold(I) azolate/phosphane complexes for the treatment of basal like breast cancer.
Gambini V; Tilio M; Maina EW; Andreani C; Bartolacci C; Wang J; Iezzi M; Ferraro S; Ramadori AT; Simon OC; Pucciarelli S; Wu G; Dou QP; Marchini C; Galassi R; Amici A
Eur J Med Chem; 2018 Jul; 155():418-427. PubMed ID: 29906688
[TBL] [Abstract][Full Text] [Related]
7. The fluxional amine gold(III) complex as an excellent catalyst and precursor of biologically active acyclic carbenes.
Montanel-Pérez S; Herrera RP; Laguna A; Villacampa MD; Gimeno MC
Dalton Trans; 2015 May; 44(19):9052-62. PubMed ID: 25893402
[TBL] [Abstract][Full Text] [Related]
8. Antiproliferative activity exerted by tricyclohexylphosphanegold(I) n-mercaptobenzoate against MCF-7 and A2780 cell lines: the role of p53 signaling pathways.
Ang KP; Chan PF; Hamid RA
Biometals; 2021 Feb; 34(1):141-160. PubMed ID: 33196940
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of lipoxygenase (LOX) and anticancer activity caused by gold(I) mixed ligands complexes of triphenylphosphine and thioamides.
Georgiou E; Metsios A; Kourkoumelis N; Karkabounas S; Charalabopoulos K; Badeka A; Hadjikakou SK
J Enzyme Inhib Med Chem; 2011 Aug; 26(4):592-7. PubMed ID: 21087193
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterisation and biological properties of gold(III) compounds with modified bipyridine and bipyridylamine ligands.
Casini A; Diawara MC; Scopelliti R; Zakeeruddin SM; Grätzel M; Dyson PJ
Dalton Trans; 2010 Mar; 39(9):2239-45. PubMed ID: 20162197
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxicity of gold(III) complexes on A549 human lung carcinoma epithelial cell line.
Arsenijević M; Milovanovic M; Volarevic V; Djeković A; Kanjevac T; Arsenijević N; Dukić S; Bugarcić ZD
Med Chem; 2012 Jan; 8(1):2-8. PubMed ID: 22420544
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships in cytotoxic Au(I)/Au(III) complexes derived from 2-(2'-pyridyl)benzimidazole.
Maiore L; Aragoni MC; Deiana C; Cinellu MA; Isaia F; Lippolis V; Pintus A; Serratrice M; Arca M
Inorg Chem; 2014 Apr; 53(8):4068-80. PubMed ID: 24679072
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of gold(I) phosphine complexes containing the 2-BrC
Reddy TS; Privér SH; Mirzadeh N; Bhargava SK
Eur J Med Chem; 2018 Feb; 145():291-301. PubMed ID: 29331752
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, structural characterisation and anti-proliferative activity of NHC gold amino acid and peptide conjugates.
Lemke J; Pinto A; Niehoff P; Vasylyeva V; Metzler-Nolte N
Dalton Trans; 2009 Sep; (35):7063-70. PubMed ID: 20449149
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of polymeric gold glyco-conjugates as anti-cancer agents.
Ahmed M; Mamba S; Yang XH; Darkwa J; Kumar P; Narain R
Bioconjug Chem; 2013 Jun; 24(6):979-86. PubMed ID: 23631753
[TBL] [Abstract][Full Text] [Related]
16. Acridine-decorated cyclometallated gold(iii) complexes: synthesis and anti-tumour investigations.
Williams MRM; Bertrand B; Fernandez-Cestau J; Waller ZAE; O'Connell MA; Searcey M; Bochmann M
Dalton Trans; 2018 Oct; 47(38):13523-13534. PubMed ID: 30204186
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of heterobimetallic gold(i) ferrocenyl-substituted 1,2,3-triazol-5-ylidene complexes as potential anticancer agents.
Aucamp D; Kumar SV; Liles DC; Fernandes MA; Harmse L; Bezuidenhout DI
Dalton Trans; 2018 Nov; 47(45):16072-16081. PubMed ID: 30276400
[TBL] [Abstract][Full Text] [Related]
18. Cytotoxicity of Pyrazine-Based Cyclometalated (C^N
Bertrand B; Fernandez-Cestau J; Angulo J; Cominetti MMD; Waller ZAE; Searcey M; O'Connell MA; Bochmann M
Inorg Chem; 2017 May; 56(10):5728-5740. PubMed ID: 28441013
[TBL] [Abstract][Full Text] [Related]
19. A Gold(III) Pincer Ligand Scaffold for the Synthesis of Binuclear and Bioconjugated Complexes: Synthesis and Anticancer Potential.
Bertrand B; O'Connell MA; Waller ZAE; Bochmann M
Chemistry; 2018 Mar; 24(14):3613-3622. PubMed ID: 29334159
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of novel heteroleptic delocalised cationic pyrazole gold complexes as potent HepG2 cytotoxic agents.
Afolabi F; Souissi W; Rivière G; Lemaitre C; Roe SM; Crickmore N; Viseux EME
Dalton Trans; 2018 Nov; 47(43):15338-15343. PubMed ID: 30276377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
